Article Data

  • Views 258
  • Dowloads 141

Original Research

Open Access

Predictors of non-invasive ventilation failure in adult patients with cardiac dysfunction presenting with community-acquired pneumonia: an Egyptian multicenter prospective study

  • Mohamed Laimoud1,*,
  • Muhammed Abdel-Moaty2
  • Mohamed Elshobary3
  • Thanaa Mohamed4
  • Walid Ahmed1

1Critical Care Medicine department, Cairo University,12613 Cairo, Egypt

2Internal Medicine department, Suez Canal hospital, 41522 Ismailia, Egypt

3Internal Medicine department, Mabara Misr Elkadima hospital, 11559 Cairo, Egypt

4Pulmonary medicine department, Mabara Misr Elkadima hospital, 11559 Cairo, Egypt

DOI: 10.22514/sv.2022.078

Submitted: 14 June 2022 Accepted: 11 August 2022

Online publish date: 18 November 2022

*Corresponding Author(s): Mohamed Laimoud E-mail: m.laimoud@cu.edu.eg

Abstract

Non-invasive ventilation (NIV) might be successful if carefully selected in adult patients with cardiac dysfunction presenting with community-acquired pneumonia. The main objective of this study was to identify the early predictors of NIV failure. Adult patients with left ventricle ejection fraction (LV EF) <50% admitted to the intensive care unit (ICU) with community-acquired pneumonia and acute respiratory failure were enrolled in this multicenter prospective study after obtaining informed consents (study registrationID: ISRCTN14641518). Non-invasive ventilation failure was defined as the requirement of intubation after initiation of NIV. All patients were assessed using the Acute Physiology and Chronic Health Evaluation II (APACHE II) and sequential organ failure assessment (SOFA) scores at admission, while their Heart rate Acidosis Consciousness Oxygenation and Respiratory rate (HACOR) and lung ultrasound (LUS) scores in addition to blood lactate were assessed at NIV initiation and 12 and 24 hours later. A total of 177 patients were prospectively enrolled from February 2019 to July 2020. Of them, 53 (29.9%) had failed NIV. The mean age of the study cohort was 64.1± 12.6 years, with a male predominance (73.4%) and a mean LV EF of 36.4 ± 7.8%. Almost 55.9% of the studied patients had diabetes mellitus, 45.8% had chronic systemic hypertension, 73.4% had ischemic heart disease, 20.3% had chronic kidney disease, and 9.6% had liver cirrhosis. No significant differences were observed between the NIV success and NIV failure groups regarding underlying morbidities or inflammatory markers. Patients who failed NIV were significantly older and had higher mean SOFA and APACHE II scores than those with successful NIV. We also found that NIV failure was associated with longer ICU stay (p < 0.001), higher SOFA scores at 48 hours (p < 0.001) and higher mortality (p < 0.001) compared with the NIV success group. In addition, SOFA (Odds Ratio (OR): 4.52, 95% Confidence Interval (CI): 2.59–7.88, p < 0.001), HACOR (OR: 2.01, 95% CI: 0.97–4.18, p = 0.036) and LUS (OR: 1.33, 95% CI: 1.014–1.106, p = 0.027) scores and blood lactate levels (OR: 9.35, 95% CI: 5.32–43.26, p < 0.001) were independent factors for NIV failure. High initial HACOR and SOFA scores, persistent hyperlactatemia and non-decrementing LUS score were associated with early NIV failure in patients with cardiac dysfunction presenting with community-acquired pneumonia, and could be used as clinical and paraclinical variables for early decision making regarding invasive ventilation.


Keywords

Non-invasive ventilation; Pneumonia; Lung ultrasound (LUS); Lactate; HACOR score; APACHE II; SOFA score; Heart failure


Cite and Share

Mohamed Laimoud,Muhammed Abdel-Moaty,Mohamed Elshobary,Thanaa Mohamed,Walid Ahmed. Predictors of non-invasive ventilation failure in adult patients with cardiac dysfunction presenting with community-acquired pneumonia: an Egyptian multicenter prospective study. Signa Vitae. 2022.doi:10.22514/sv.2022.078.

References

[1] Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012; 125: 773–781.

[2] Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. The Lancet. Infectious Diseases. 2010; 10: 83–92.

[3] Masip J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, et al. Indications, and practical approach to non-invasive ventilation in acute heart failure. European Heart Journal. 2018; 39: 17–25.

[4] Park JJ, Choi D, Yoon C, Oh I, Lee JH, Ahn S, et al. The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry. European Journal of Heart Failure. 2015; 17: 601–611.

[5] Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. European Heart Journal. 2010; 31: 832–841.

[6] Tobin MJ. Advances in mechanical ventilation. New England Journal of Medicine. 2001; 344: 1986–1996.

[7] Lin M, Yang Y, Chiang H, Chang M, Chiang BN, Cheitlin MD. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest. 1995; 107: 1379–1386.

[8] Bradley TD, Holloway RM, McLaughlin PR, Ross BL, Walters J, Liu PP. Cardiac output response to continuous positive airway pressure in congestive heart failure. American Review of Respiratory Disease. 1992; 145: 377–382.

[9] Jolliet P, Abajo B, Pasquina P, Chevrolet JC. Non-invasive pressure support ventilation in severe community-acquired pneumonia. Intensive Care Med. 2001; 27: 812–821.

[10] He H, Sun B, Liang L, Li Y, Wang H, Wei L, et al. A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome. Critical Care. 2019; 23: 300.

[11] Antonelli M, Conti G, Esquinas A, Montini L, Maggiore SM, Bello G, et al. A multicenter survey on the use in clinical practice of non-invasive ventilation as a first line intervention for acute respiratory distress syndrome. Critical Care Medicine. 2007; 35: 18–25.

[12] Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of noninvasive ventilation delivered by helmet vs. face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome. JAMA. 2016; 315: 2435.

[13] Bellani G, Laffey JG, Pham T, Madotto F, Fan E, Brochard L, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. American Journal of Respiratory and Critical Care Medicine. 2017; 195: 67–77.

[14] Booth A. Clear and present questions: formulating questions for evidence based practice. Library Hi Tech. 2006; 24: 355–368.

[15] Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure. American Journal of Respiratory and Critical Care Medicine. 2003; 168: 1438–1444.

[16] Agarwal R, Handa A, Aggarwal AN, Gupta D, Behera D. Outcomes of non-invasive ventilation in acute hypoxemic respiratory failure in a respiratory intensive care unit in north India. Respiratory Care. 2009; 54: 1679–1687.

[17] Carron M, Freo U, Zorzi M, Ori C. Predictors of failure of noninvasive ventilation in patients with severe community-acquired pneumonia. Journal of Critical Care. 2010; 25: 540.e9–540.e14.

[18] Muriel A, Peñuelas O, Frutos-Vivar F, Arroliga AC, Abraira V, Thille AW, et al. Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis. Intensive Care Medicine. 2015; 41: 1586–1600.

[19] Yoshida Y, Takeda S, Akada S, Hongo T, Tanaka K, Sakamoto A. Factors predicting successful noninvasive ventilation in acute lung injury. Journal of Anesthesia. 2008; 22: 201–206.

[20] Masclans JR, Pérez M, Almirall J, Lorente L, Marqués A, Socias L, et al. Early non-invasive ventilation treatment for severe influenza pneumonia. Clinical Microbiology and Infection. 2013; 19: 249–256.

[21] Ozyilmaz E, Ugurlu AO, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulmonary Medicine. 2014; 14: 19.

[22] Antonelli M, Conti G, Moro M, Esquinas A, Gonzalez-Diaz G, Confalonieri M, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Medicine. 2001; 27: 1718–1728.

[23] Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Medicine. 2017; 43: 192–199.

[24] Duan J, Wang S, Liu P, Han X, Tian Y, Gao F, et al. Early prediction of non-invasive ventilation failure in COPD patients: derivation, internal validation, and external validation of a simple risk score. Annals of Intensive Care. 2019; 9: 108.

[25] Todur P, Souvik Chaudhuri FNB Critical Care, Vedaghosh Amara FNB Critical Care, Srikant N, Prakash P. Correlation of oxygenation and radiographic assessment of lung edema (RALE) score to lung ultrasound score (LUS) in acute respiratory distress syndrome (ARDS) patients in the intensive care unit. Canadian Journal of Respiratory Therapy. 2021; 57: 53–59.

[26] Soliman SB, Ragab F, Soliman RA, Gaber A, Kamal A. Chest ultrasound in predication of weaning failure. Open Access Macedonian Journal of Medical Sciences. 2019; 7: 1143–1147.

[27] Rodríguez A, Ferri C, Martin-Loeches I, Díaz E, Masclans JR, Gordo F, et al. Risk factors for noninvasive ventilation failure in critically ill subjects with confirmed influenza infection. Respiratory Care. 2017; 62: 1307–1315.

[28] Ozyilmaz E, Ugurlu AO, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulmonary Medicine. 2014; 14: 19.

[29] Confalonieri M. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. European Respiratory Journal. 2005; 25: 348–355.

[30] Moretti M. Incidence and causes of non-invasive mechanical ventilation failure after initial success. Thorax. 2000; 55: 819–825.

[31] Rana S, Jenad H, Gay PC, Buck CF, Hubmayr RD, Gajic O. Failure of non-invasive ventilation in patients with acute lung injury: observational cohort study. Critical Care. 2006; 10: R79.

[32] Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. The Lancet. 2009; 374: 250–259.

[33] Ferrer M, Cosentini R, Nava S. The use of non-invasive ventilation during acute respiratory failure due to pneumonia. European Journal of Internal Medicine. 2012; 23: 420–428.

[34] Sarnoff SJ, Braunwald E, Welch GH, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. American Journal of Physiology-Legacy Content. 1957; 192: 148–156.

[35] Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C. Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation. 1995; 92: 342–347.

[36] Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. New England Journal of Medicine. 1989; 321: 280–287.

[37] Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction. Chest. 2006; 129: 1349–1366.

[38] Habimana R, Choi I, Cho HJ, Kim D, Lee K, Jeong I. Sepsis-induced cardiac dysfunction: a review of pathophysiology. Acute and Critical Care. 2020; 35: 57–66.

[39] Kakihana Y, Ito T, Nakahara M, Yamaguchi K, Yasuda T. Sepsis-induced myocardial dysfunction: pathophysiology and management. Journal of Intensive Care. 2016; 4: 22.

[40] Ferreira FL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001; 286: 1754.

[41] Laimoud M, Alanazi M. The validity of SOFA score to predict mortality in adult patients with cardiogenic shock on venoarterial extracorporeal membrane oxygenation. Critical Care Research and Practice. 2020; 2020: 1–9.

[42] Lambden S, Laterre PF, Levy MM, Francois B. SOFA score—development, utility and challenges of ac-curate assessment in clinical trials. Critical Care. 2019; 23: 374.

[43] Liengswangwong W, Yuksen C, Thepkong T, Nakasint P, Jenpanitpong C. Early detection of non-invasive ventilation failure among acute respiratory failure patients in the emergency department. BMC Emergency Medicine. 2020; 20: 80.

[44] Schiavo A, Renis M, Polverino M, Iannuzzi A, Polverino F. Acid–base balance, serum electrolytes and need for non-invasive ventilation in patients with hypercapnic acute exacerbation of chronic obstructive pulmonary disease admitted to an internal medicine ward. Multidisciplinary Respiratory Medicine. 2016; 11: 23.

[45] Laimoud M, Alanazi M. The clinical significance of blood lactate levels in evaluation of adult patients with veno-arterial extracorporeal membrane oxygenation. The Egyptian Heart Journal. 2020; 72: 74.

[46] Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Annals of Emergency Medicine. 2005; 45: 524–528.

[47] Schollin-Borg M, Nordin P, Zetterström H, Johansson J. Blood lactate is a useful indicator for the medical emergency team. Critical Care Research and Practice. 2016; 2016: 1–7.

[48] Biasucci DG, Buonsenso D, Piano A, Bonadia N, Vargas J, Settanni D, et al. Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study. Minerva Anestesiologica. 2021; 87: 1006–1016.

[49] Staub LJ, Mazzali Biscaro RR, Kaszubowski E, Maurici R. Lung ultrasound for the emergency diagnosis of pneumonia, acute heart failure, and exacerbations of chronic obstructive pulmonary disease/asthma in adults: a systematic review and meta-analysis. The Journal of Emergency Medicine. 2019; 56: 53–69.

[50] Long L, Zhao HT, Zhang ZY, Wang GY, Zhao HL. Lung ultrasound for the diagnosis of pneumonia in adults: a meta-analysis. Medicine. 2017; 96: e5713.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top